(wada-ama.org) The clinical bottom line (Meto-style) AOD-9604 is a legitimate fat-metabolism peptide in the sense that it has: a plausible mechanism, preclinical support, and a history of controlled human trials
Methylcobalamin is often promoted as superior due to its 'bioactive' status, but clinical evidence supporting significantly better outcomes compared to cyanocobalamin is limited
When there are issues, there are also quick resolutions
Accessed December 4, 2025
Thus, a deficiency in vitamin B12 may impact the production and function of those neurotransmitters
However, other factors can contribute to or cause neuropathy, including vitamin deficiencies (particularly B vitamins), alcohol use, certain medications, autoimmune conditions, infections, and inherited disorders